Bright Peak Therapeutics Announces $107 Million Series B globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
Proceeds to advance company's pipeline of next-generation cytokine immunotherapies Laura Shawver, Christine Siu join as independent directors BASEL, Switzerland and SAN DIEGO, Calif., June 10
Bright Peak Therapeutics Announces $107 Million Series B Financing and Expanded Board of Directors | Comunicados | Edición USA efe.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from efe.com Daily Mail and Mail on Sunday newspapers.
Versant Ventures Raises $950 Million Across Three Vehicles $140 million companion fund to boost selected early high-performers $250 million opportunity fund for later-stage rounds
Versant Ventures today announced $950 million in additional capital allocated across a platform of three separate vehicles. These included Versant Venture Capital VIII, a $560 million primary global biotech fund; Versant Voyageurs II, a $140 million booster fund; and Versant Vantage II, a $250 million later-stage opportunity fund.
All three funds exceeded their initial targets and were heavily oversubscribed. The capital from existing investors and a select number of new top-tier limited partners will support Versant s highly successful biotech investment strategy and portfolio construction model.